1. 1 Ameur N, Lacroix L, Roucan S, Roux V, Broutin S, Talbot M, Dupuy C, Caillou B, Schlumberger M and Bidart JM (2009) Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways. Endocr Relat Cancer16, 1261–1272.
2. 2 Beauchemin N and Arabzadeh A (2013) Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in can cer progression and metastasis. Cancer Metastasis Rev32, 643–671.
3. 3 Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Frank M, Schmidberger H, Raue F and Becker W (1997) Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Cancer Res57, 5309–5319.
4. 4 Bergholm U, Bergstrom R and Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thy roid. Cancer79, 132–138.
5. 5 Berling B, Kolbinger F, Grunert F, Thompson JA, Brombacher F, Buchegger F, von Kleist S and Zimmermann W (1990) Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res50, 6534–6539.